Aptevo Therapeutics Inc (NQ: APVO )

32.61 USD -3.96 (-10.83%)

Official Closing Price Updated: 7:06 PM EST, Jan 27, 2021 Add to My Watchlist

Price and Volume

Volume	114,200
Open	35.66
Bid (Size)	33.25 (1)
Ask (Size)	37.73 (1)
Prev. Close	36.57
Today's Range	32.50 - 36.40
52wk Range	0.2103 - 60.00
Shares Outstanding	22,586,132
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Aptevo Therapeutics Provides Update on Ongoing APVO436 Phase 1 Clinical Trial

January 11, 2021

Aptevo Therapeutics Announces the Launch of Its Second Platform Technology ADAPTIR-FLEX(TM) and Introduces the New Bispecific Prostate Cancer Candidate APVO442

December 02, 2020

Performance

YTD	-12.29%	-12.29%
1 Month	-4.70%	-4.70%
3 Month	+425.12%	+425.12%
6 Month	+291.01%	+291.01%
1 Year	+5064.71%	+5064.71%

More News

Aptevo Confirms Receipt of Unsolicited Indication of Interest

November 19, 2020

Aptevo Therapeutics and Alligator Bioscience advancing the bispecific 4-1BBx5T4 antibody ALG.APV-527 into Phase I clinical development

November 16, 2020

Aptevo Therapeutics is Now Oversold (APVO)

January 19, 2021

Medexus Reaches 50% Enrollment in IXINITY® Phase 4 Clinical Trial Targeting Label Expansion for Pediatric Hemophilia B Patients

November 16, 2020

Aptevo Therapeutics and Alligator Bioscience Advancing the Bispecific 4-1BBx5T4 Antibody ALG.APV-527 Into Phase 1 Clinical Development

November 16, 2020

RSI Alert: Aptevo Therapeutics (APVO) Now Oversold

December 29, 2020

Mid-Afternoon Market Update: Dow Turns Positive; Medigus Shares Spike Higher

November 19, 2020

12 Healthcare Stocks Moving In Thursday's Intraday Session

November 19, 2020

Mid-Day Market Update: Nasdaq Rises 50 Points; MeiraGTx Shares Plunge

November 19, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.